TORONTO (CIDRAP News) The continuing debate over developing countries' ability to afford pandemic-influenza vaccines has produced a disturbing complication: the possibility that Indonesia and other countries affected by H5N1 avian flu will assert legal ownership of the viral isolates on which the vaccines would be based.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) today confirmed 20 more swine influenza cases, all connected to previous cases at a New York City high school, and said federal officials will issue new travel advice urging against nonessential travel to Mexico.
WHO's novel H1N1 flu case count tops 4,500The global number of people infected with the novel H1N1 influenza (swine flu) virus rose to 4,694 from 30 countries, the World Health Organization (WHO) reported today. The count includes 1,626 cases and 48 deaths in Mexico and the 2,532 cases and 3 deaths reported in the United States as of yesterday. Canada has reported 284 cases and one death. [WHO update 25]